EUPRAXIA PHARMACEUTICALS INC.
(EPRX)Financial Statements · SEC EDGAR XBRL
Revenue
$0
Net Income
-$38.6M
-51.3%
EPS
$-1.03
-35.5%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)